GAZZINA, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 1.415
EU - Europa 670
AS - Asia 500
OC - Oceania 5
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.595
Nazione #
US - Stati Uniti d'America 1.409
CN - Cina 193
SG - Singapore 156
DE - Germania 151
IT - Italia 134
HK - Hong Kong 85
UA - Ucraina 85
FI - Finlandia 72
GB - Regno Unito 60
RU - Federazione Russa 54
TR - Turchia 47
IE - Irlanda 43
FR - Francia 27
CZ - Repubblica Ceca 17
PL - Polonia 14
AU - Australia 5
CA - Canada 5
IN - India 5
ID - Indonesia 4
SE - Svezia 4
BR - Brasile 3
NL - Olanda 3
AT - Austria 2
BE - Belgio 2
CH - Svizzera 2
IR - Iran 2
JP - Giappone 2
SA - Arabia Saudita 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
DO - Repubblica Dominicana 1
EU - Europa 1
PE - Perù 1
Totale 2.595
Città #
Fairfield 197
Singapore 132
Ashburn 113
Woodbridge 105
Houston 97
Chandler 88
Hong Kong 85
New York 85
Helsinki 69
Jacksonville 69
Cambridge 68
Seattle 63
Wilmington 58
Princeton 55
Dearborn 53
Dublin 43
Istanbul 43
Brescia 36
Shanghai 25
Nanjing 24
Los Angeles 23
Ann Arbor 19
Boardman 18
Beijing 17
Munich 16
Moscow 15
Olomouc 14
Warsaw 14
Milan 13
San Diego 12
Changsha 10
Hebei 9
Jinan 9
Norwalk 9
Shenyang 9
Des Moines 8
Nanchang 8
Romola 8
London 7
Rome 7
Guangzhou 6
Lancaster 6
Honolulu 5
Washington 5
Augusta 4
Jakarta 4
Orzinuovi 4
Arezzo 3
Avigliana 3
Brno 3
Chiswick 3
Haikou 3
Hounslow 3
Islington 3
Kocaeli 3
New Bedfont 3
Ningbo 3
Nürnberg 3
Redwood City 3
Rio Saliceto 3
Santa Clara 3
Toronto 3
Belluno 2
Berlin 2
Bienno 2
Brussels 2
Calcio 2
Chicago 2
Dong Ket 2
Falkenstein 2
Gunzenhausen 2
Hangzhou 2
Jiaxing 2
Kilburn 2
Kunming 2
La Seyne-sur-Mer 2
Leipzig 2
Melbourne 2
New Delhi 2
Perth 2
Riyadh 2
San Francisco 2
São Paulo 2
Taiyuan 2
Taizhou 2
Tesero 2
Tianjin 2
Torino 2
Verona 2
Zhengzhou 2
Zurich 2
Albino 1
Barlassina 1
Catania 1
Chester 1
Clifton 1
Cremona 1
Espoo 1
Faggiano 1
Frankfurt am Main 1
Totale 1.899
Nome #
Mild Cognitive Impairment and Progression to Dementia in Progressive Supranuclear Palsy 165
Source-Based Morphometry Multivariate Approach to Analyze [123I]FP-CIT SPECT Imaging 159
Mendelian forms of disease and age at onset affect survival in frontotemporal dementia 150
COVID-19 impact on consecutive neurological patients admitted to the emergency department 148
Autoimmunity and frontotemporal dementia 125
Iron in Frontotemporal Lobar Degeneration: A New Subcortical Pathological Pathway? 115
Diagnosing Progressive Supranuclear Palsy: Role of Biological and Neuroimaging Markers 112
Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia 111
Overlap between frontotemporal dementia and alzheimer's disease: Cerebrospinal fluid pattern and neuroimaging study 106
Natural history and predictors of survival in progressive supranuclear palsy. 105
Neuroanatomical Correlates of Transcranial Magnetic Stimulation in Presymptomatic Granulin Mutation Carriers. 94
Myoclonic dystonia (DYT11) responsive to insulin therapy: A case report. 89
Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy 89
Progression of behavioural disturbances in frontotemporal dementia: a longitudinal observational study 78
Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study 50
Steroid-Responsive Encephalitis in Coronavirus Disease 2019 49
Progression of Behavioral Disturbances and Neuropsychiatric Symptoms in Patients With Genetic Frontotemporal Dementia 49
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration 45
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 45
Hierarchical spectral clustering reveals brain size and shape changes in asymptomatic carriers of C9orf72 43
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 42
Dissemination in time and space in presymptomatic granulin mutation carriers: a GENFI spatial chronnectome study 42
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 40
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 40
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 38
Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study 37
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 37
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort 35
Differential early subcortical involvement in genetic FTD within the GENFI cohort 35
Structural brain splitting is a hallmark of Granulin-related frontotemporal dementia 34
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 33
Impairment of episodic memory in genetic frontotemporal dementia: A genfi study 32
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 30
Neurotransmitter imbalance dysregulates brain dynamic fluidity in frontotemporal degeneration 30
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 30
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration 29
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 28
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 27
Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions 25
Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease 23
Prognostic Usefulness of Motor Unit Number Index (MUNIX) in Patients Newly Diagnosed with Amyotrophic Lateral Sclerosis 21
Electrophysiological neuromuscular alterations and severe fatigue predict long-term muscle weakness in survivors of COVID-19 acute respiratory distress syndrome 20
Sex-differences in the longitudinal recovery of neuromuscular function in COVID-19 associated acute respiratory distress syndrome survivors 18
QEEG abnormalities in cognitively unimpaired patients with delirium 17
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 8
Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum 7
Totale 2.685
Categoria #
all - tutte 20.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020301 0 0 0 0 0 66 66 51 36 50 8 24
2020/2021448 15 34 14 32 64 69 12 32 56 49 52 19
2021/2022251 17 24 5 4 1 17 25 21 17 38 27 55
2022/2023322 29 11 22 12 31 84 8 26 46 2 24 27
2023/2024511 32 16 65 33 14 116 15 21 89 22 5 83
2024/2025390 7 11 13 185 89 85 0 0 0 0 0 0
Totale 2.685